Presentation ACC 2026 IVUS or angiography guidance for PCI in complex coronary bifurcation lesions: The DKCRUSH VIII Trial Presenter: Shao-Liang Chen March 30, 2026
News Conference News ACC 2026 PCSK9 Inhibitor Very Effective in High-risk Patients Without ASCVD: VESALIUS-CV Michael O'Riordan March 29, 2026
News Conference News ACC 2026 Very Low LDL Levels Best in Secondary Prevention: Ez-PAVE Yael L. Maxwell March 28, 2026
News Conference News ACC 2026 KARDINAL: Monthly Tonlamarsen May Not Enhance BP Lowering in Resistant Hypertension Caitlin E. Cox March 28, 2026
Presentation ACC 2026 Evolocumab in Patients without Known Atherosclerosis and with Diabetes: Secondary Analysis from VESALIUS-CV Presenter: Nicholas Marston March 28, 2026
Presentation ACC 2026 Groceries for Black Residents of Boston to Stop Hypertension among Adults with Treated Hypertension (GoFreshRx) Presenter: Stephen Paul Juraschek March 28, 2026
Presentation ACC 2026 Intensive LDL cholesterol targeting in atherosclerotic cardiovascular disease: The Ez-PAVE randomized clinical trial Presenter: Byeong-Keuk Kim March 28, 2026
News Daily News Benefits of Early SAVR for Asymptomatic Aortic Stenosis Persist a Decade On Todd Neale March 26, 2026
News Daily News Epicardial Fat Shows Promise as a Clinical Risk Factor for CAD Yael L. Maxwell March 24, 2026
News Daily News Several Factors Linked to Subsequent Events After TIA, Minor Stroke Todd Neale March 23, 2026
News Daily News Premature Menopause Increases Lifetime Heart Disease Risk Regardless of Race L.A. McKeown March 23, 2026
News Daily News Positive Top-line Results for Retatrutide in Diabetes: TRANSCEND-T2D-1 Caitlin E. Cox March 19, 2026
News Daily News No Major Progress on Making CV Care More Affordable: JACC Stats Todd Neale March 18, 2026
News Daily News Ultraprocessed Food Again Linked to Higher CVD Risk: MESA Michael O'Riordan March 17, 2026
News Daily News Lower LDL Levels, Starting Earlier in Life: New ACC/AHA Dyslipidemia Guidelines Michael O'Riordan March 13, 2026
News Conference News CRT 2026 AGENT IDE Midterm Results Still Give DCB an Edge for In-Stent Restenosis L.A. McKeown March 11, 2026
News Conference News CRT 2026 Large Variability in Use of Invasive Strategy for Type 1 NSTEMI: NCDR Michael O'Riordan March 11, 2026